Drug
LYS-006 clinical trials
Also written LYS006.
- studies test it
- 4
- open now
- 0
- in phase 3
- 0
- first study started
- 2018
How studies write it
Studies that test it under each name
Development codes
Studies by the year they started
4 studies that test it; most in 2020 (2)
| Year | Studies |
|---|---|
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 2 |
By phase
A phase 1/2 study counts in both.
- Phase 2
- 4
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 4 · Other 0
Often tested with
Tested in the same studies.
Iscalimab (1) · Arumakimig (1) · Remibrutinib (1) · Ianalumab (1) · Tropifexor (1)
Studies
Open first, then newest update. How each study uses LYS-006 is read from its arms, and is right about nine times in ten.
Testing it · 4
- Study of Efficacy and Safety of Investigational Treatments in Patients With Moderate to Severe Hidradenitis SuppurativaCompletedPhase 2Novartis PharmaceuticalsNCT03827798Written as LYS006
- Study of Efficacy, Safety, and Tolerability of LYS006, in Patients With Mild to Moderate Ulcerative ColitisTerminatedPhase 2Novartis PharmaceuticalsNCT04074590Written as LYS006
- Study to Assess the Efficacy and Safety of LYS006 in Patients With Moderate to Severe Inflammatory AcneCompletedPhase 2Novartis PharmaceuticalsNCT03497897Written as LYS006 20 mg
- Study of Various Treatments in Non-alcoholic Fatty Liver Disease (NAFLD) Patients Who Have Aspects of Non-alcoholic Steatohepatitis (NASH)TerminatedPhase 2Novartis PharmaceuticalsNCT04147195Written as LYS006